Fanconi Anemia

Sundin
Illustration of a Stanford researcher with briquilimab antibody vial in a lab, representing a new stem cell transplant method for Fanconi anemia.
Larawang ginawa ng AI

Stanford antibody regimen enables stem cell transplants without radiation or busulfan in Fanconi anemia

Iniulat ng AI Larawang ginawa ng AI Fact checked

A Stanford Medicine team reports that a single dose of the anti‑CD117 antibody briquilimab allowed three children with Fanconi anemia to undergo stem cell transplants without radiation or busulfan, achieving near‑complete donor cell engraftment in a phase 1b study published in Nature Medicine.

Gumagamit ng cookies ang website na ito

Gumagamit kami ng cookies para sa analytics upang mapabuti ang aming site. Basahin ang aming patakaran sa privacy para sa higit pang impormasyon.
Tanggihan